These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 21035741)

  • 21. Clozapine-induced myoclonus and generalized seizures.
    Sajatovic M; Meltzer HY
    Biol Psychiatry; 1996 Mar; 39(5):367-70. PubMed ID: 8704069
    [No Abstract]   [Full Text] [Related]  

  • 22. Clozapine maintenance therapy in schizophrenia.
    Gaszner P; Makkos Z
    Prog Neuropsychopharmacol Biol Psychiatry; 2004 May; 28(3):465-9. PubMed ID: 15093952
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Glycine transporter I inhibitor, N-methylglycine (sarcosine), added to clozapine for the treatment of schizophrenia.
    Lane HY; Huang CL; Wu PL; Liu YC; Chang YC; Lin PY; Chen PW; Tsai G
    Biol Psychiatry; 2006 Sep; 60(6):645-9. PubMed ID: 16780811
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clozapine in patients with chronic schizophrenia: serum level, EEG and memory performance.
    Adler G; Grieshaber S; Faude V; Thebaldi B; Dressing H
    Pharmacopsychiatry; 2002 Sep; 35(5):190-4. PubMed ID: 12237790
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Management of treatment refractory schizophrenia.
    Morrison DP
    Br J Psychiatry Suppl; 1996 Dec; (31):15-20. PubMed ID: 8968651
    [No Abstract]   [Full Text] [Related]  

  • 26. Subjective response to clozapine and risperidone treatment in outpatients with schizophrenia.
    Kim JH; Kim SY; Ahn YM; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2006 Mar; 30(2):301-5. PubMed ID: 16309807
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 28. Correlation between delay in initiating clozapine and symptomatic improvement.
    Yada Y; Yoshimura B; Kishi Y
    Schizophr Res; 2015 Oct; 168(1-2):585-6. PubMed ID: 26255084
    [No Abstract]   [Full Text] [Related]  

  • 29. Sleep EEG and spindle characteristics after combination treatment with clozapine in drug-resistant schizophrenia: a pilot study.
    Tsekou H; Angelopoulos E; Paparrigopoulos T; Golemati S; Soldatos CR; Papadimitriou GN; Ktonas PY
    J Clin Neurophysiol; 2015 Apr; 32(2):159-63. PubMed ID: 25350635
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy of clozapine in the treatment of atypical antipsychotic refractory schizophrenia: a pilot study.
    Narendran R; Young CM; Pristach CA; Pato MT; Valenti AM; Fass AR
    J Clin Psychopharmacol; 2003 Feb; 23(1):103-4. PubMed ID: 12544385
    [No Abstract]   [Full Text] [Related]  

  • 31. EEG abnormalities before clozapine therapy predict a good clinical response to clozapine.
    Pillay SS; Stoll AL; Weiss MK; Tohen M; Zarate CA; Banov MD; Cole JO
    Ann Clin Psychiatry; 1996 Mar; 8(1):1-5. PubMed ID: 8743641
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lithium enabling use of clozapine in a patient with pre-existing neutropenia.
    Hodgson RE; Mendis S
    Br J Hosp Med (Lond); 2010 Sep; 71(9):535. PubMed ID: 20852555
    [No Abstract]   [Full Text] [Related]  

  • 33. Quantitative biomarkers to predict response to clozapine treatment using resting EEG data.
    Masychev K; Ciprian C; Ravan M; Manimaran A; Deshmukh A
    Schizophr Res; 2020 Sep; 223():289-296. PubMed ID: 32928617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Non-linear dynamic analysis of clozapine-induced electroencephalographic changes in schizophrenic patients--a preliminary study.
    Kang UG; Par KT; Ahn YM; Koo YJ; Yoon SC; Yi SH; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2001 Aug; 25(6):1229-39. PubMed ID: 11474842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. EEG coherence following acute and chronic clozapine in treatment-resistant schizophrenics.
    Knott VJ; LaBelle A; Jones B; Mahoney C
    Exp Clin Psychopharmacol; 2002 Nov; 10(4):435-44. PubMed ID: 12498341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adjunctive ondansetron in schizophrenia--A pilot study.
    Hema T; Maran S; Subhashini G
    Asian J Psychiatr; 2016 Feb; 19():66-7. PubMed ID: 26957341
    [No Abstract]   [Full Text] [Related]  

  • 37. Topographic analysis of EEG photic driving in patients with schizophrenia following clozapine treatment.
    Jin Y; Potkin SG; Sandman CA; Bunney WE
    Clin Electroencephalogr; 1998 Apr; 29(2):73-8. PubMed ID: 9571294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The clinical correlation and predictive value of electrophysiological variables on clinical response to clozapine in patients with treatment-resistant schizophrenia.
    Gica S; Buyukavsar A; Poyraz BC; Gulec H
    Schizophr Res; 2019 Sep; 211():108-110. PubMed ID: 31331783
    [No Abstract]   [Full Text] [Related]  

  • 39. A machine learning approach using P300 responses to investigate effect of clozapine therapy.
    Ravan M; MacCrimmon D; Hasey G; Reilly JP; Khodayari-Rostamabad A
    Annu Int Conf IEEE Eng Med Biol Soc; 2012; 2012():5911-4. PubMed ID: 23367274
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A retrospective study of clozapine and electroencephalographic abnormalities in schizophrenic patients.
    Chung SJ; Jeong SH; Ahn YM; Kang UG; Koo YJ; Ha JH; Lee SG; Kim YS
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Jan; 26(1):139-44. PubMed ID: 11853104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.